Jonathan Linton

An optimized gene knock-out strategy for human CD34+ hematopoietic stem and progenitor cells .

P. Paddison, A. Rongvaux, D. Kuppers, 2022 .

Gene knock-outs in human CD34+ hematopoietic stem and progenitor cells and in the human immune system of mice

P. Paddison, A. Rongvaux, K. McKenna, 2022, bioRxiv.

Targeting an alternate Wilms’ tumor antigen 1 peptide bypasses immunoproteasome dependency

Thomas M. Schmitt, J. Bielas, M. Bar, 2022, Science Translational Medicine.